Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Bi-sdAb) is designed to be expressed as a VHH from anti-CD64 antibody variable domains fused with a VHH from an anti-HER2 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD64 VHH x Anti-HER2 VHH BispecificAntibody (Bi-sdAb) (BIVHH-039). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS